Comparing FDA vs EMA Approaches to Stability Studies
When preparing a regulatory submission for global markets, pharmaceutical companies must navigate differing expectations from agencies like the USFDA and the European Medicines Agency (EMA). Although both follow ICH guidelines, the interpretation, implementation, and documentation of stability studies can vary. In this tutorial, we break down the core differences and actionable tips for compliance. 📝…
Read More “Comparing FDA vs EMA Approaches to Stability Studies” »